Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450537 · ClinicalTrials.gov registry record · NA
PACE Vape Messaging Study
A NA study of Vaping and Electronic Cigarette Use, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 569
- Enrollment target
- 1
- Study location
NCT04450537: Completed NA study of Vaping and Electronic Cigarette Use, sponsored by University of Vermont.
NCT04450537 is a NA study of Vaping and Electronic Cigarette Use that has completed, run by University of Vermont. The registered enrollment target is 569 participants, below the 729-participant average among 18 other Vaping trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04450537, a NA study of Vaping and Electronic Cigarette Use, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 569 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect of exposure to vape education messages on beliefs, perceptions, norms, and behaviors related to electronic vapor product use.
Primary Outcome
True/false/don't know questions about nicotine and electronic vapor/tobacco products
Conditions Studied
Interventions
- BEHAVIORAL Vape Messaging Intervention
Study Locations (1)
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
What the finished NCT04450537 record still lists
NCT04450537 is an interventional study that assigns participants to a tested intervention. The registered 569 participants enrollment target is mid-sized for trials with a published cap, below the 729-participant average among 18 other Vaping trials with a reported enrollment target (22% lower).
The record links to 3 conditions, with Vaping appearing as the primary indexed condition, and to 1 intervention - of which Vape Messaging Intervention is the first listed.
NCT04450537 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT04450537 about?
NCT04450537 is a clinical study titled "PACE Vape Messaging Study". The purpose of this study is to examine the effect of exposure to vape education messages on beliefs, perceptions, norms, and behaviors related to electronic vapor product use.
What is the current status of trial NCT04450537?
This trial is currently completed. It is a NA study. The enrollment target is 569 participants. The study started on 2020-06-23. Estimated completion is 2020-09-30.
What conditions does trial NCT04450537 study?
This clinical trial studies the following conditions: Vaping, Electronic Cigarette Use, E-cigarette Use.
What interventions are being tested in trial NCT04450537?
The interventions under investigation include: Vape Messaging Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450537?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04450537 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04450537's enrollment target sits among peer trials
569 5th of 18 higher than 14 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI